Amedisys Inc (AMED) by event type
AMED moves most on rating reiterations — a median of -0.10% at 30 minutes across 13 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the AMED overview →
How AMED reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations 904 of 2,283 | 25 | +0.09% | 64% | +0.04% |
| Rating reiterations 2,558 of 3,522 | 13 | -0.10% | 46% | +0.17% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how AMED usually reacts — get an email when it moves on news →Every name measured for these event types: Coverage initiations → · Rating reiterations → · AMED overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Biomerica, Inc. (BMRA) | 135 | 0.00% | 49% |
| BioStem Technologies, Inc. (BSEM) | 135 | +0.30% | 53% |
| ISODIOL INTERNATIONAL INC (ISOLF) | 134 | +0.20% | 52% |
| ContextLogic Inc. (LOGC) | 132 | 0.00% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.